New treatment option for Amblyopia
Official title Binocular Visual Therapy and Video Games for Amblyopia Treatment.
ClinicalTrials.gov ID: NCT03655912
What this study is testing
- What it's testing
- Amblyopia, or lazy eye, is best defined by the American Academy of Ophthalmology as a unilateral or bilateral reduction of the best corrected visual acuity that occurs in the setting of an otherwise normal eye, or a structural abnormality involving the eye or visual pathway with reduction in visual acuity that cannot be attributed only to the effect of the structural abnormality. Which causes an abnormal visual experience early in life, with consequences such as deficiencies in the ability to perceive contrast and/or movement, visual acuity, accommodation and stereopsis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 4 to 10
You may be able to join if
- Patients with anisometropic amblyopia, strabismic amblyopia or both
- Patients with out previous amblyopia treatment
- Patient with previous strabismus surgery or use of there best corrected visual acuity glasses for at least 1 month
- Birth at term gestational age
- Without any systemic or ophthalmic comorbidities
You likely can't join if
- Any other amblyopia diagnosis (deprivation)
- Any previous amblyopia treatment
- Any previous intraocular surgery
- Any ocular condition
- Any neurologic conditions or psychomotor development alterations
- Patients not able to cooperate for visual acuity or stereopsis evaluation
See the full eligibility criteria
- Patients with anisometropic amblyopia, strabismic amblyopia or both
- Patients with out previous amblyopia treatment
- Patient with previous strabismus surgery or use of there best corrected visual acuity glasses for at least 1 month
- Birth at term gestational age
- Without any systemic or ophthalmic comorbidities
- Previous patients parent verbal and fiscal assessment.
- Any other amblyopia diagnosis (deprivation)
- Any previous amblyopia treatment
- Any previous intraocular surgery
- Any ocular condition
- Any neurologic conditions or psychomotor development alterations
- Patients not able to cooperate for visual acuity or stereopsis evaluation
The study team makes the final eligibility decision.
Where it's taking place
- Monterrey, Nuevo León, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 4 years to 10 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Monterrey, Nuevo León, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.